Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

neuroendocrine tumours

  • Open Access
    Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours
    DANIELLE BOLLER, KATHRIN T. DOEPFNER, ANGELA DE LAURENTIIS, ANA S. GUERREIRO, MARIN MARINOV, TAREK SHALABY, PAUL DEPLEDGE, ANTHONY ROBSON, NAHID SAGHIR, MASAHIKO HAYAKAWA, HIROYUKI KAIZAWA, TOMONOBU KOIZUMI, TAKAHIDE OHISHI, SARAH FATTET, OLIVIER DELATTRE, ANELIA SCHWERI-OLAC, KATRIN HÖLAND, MICHAEL A. GROTZER, KARL FREI, OLIVIER SPERTINI, MICHAEL D. WATERFIELD and ALEXANDRE ARCARO
    Anticancer Research June 2022, 42 (6) 3217-3230; DOI: https://doi.org/10.21873/anticanres.15812
  • You have access
    Role of Interferon-alpha in Patients with Neuroendocrine Tumors: A Retrospective Study
    EITAN MIRVIS, DALVINDER MANDAIR, JORGE GARCIA-HERNANDEZ, MULLAN MOHMADUVESH, CHRISTOS TOUMPANAKIS and MARTYN CAPLIN
    Anticancer Research November 2014, 34 (11) 6601-6607;
  • You have access
    Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting
    CHRISTINE RANGGER, ANNA HELBOK, MELTEM OCAK, THORSTEN RADOLF, FRITZ ANDREAE, IRENE J. VIRGOLINI, ELISABETH VON GUGGENBERG and CLEMENS DECRISTOFORO
    Anticancer Research April 2013, 33 (4) 1537-1546;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire